Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Karolinska Institute, Sweden

ESMO 33

12 - 16 Sep 2008

Published: 4 Dec 2008

Views: 15983

Rating:

Save

Prof. Matthias Löhr

New drug substantially extends survival in pancreatic cancer.

Categories:
Hepatobiliary pancreatic

Related Videos

Cabozantinib demonstrates significant improvement in PFS by BICR in advanced...

Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA

Cabozantinib demonstrates significant improvement in PFS by BICR in advanced neuroendocrine tumours ( Dr Jennifer Chan - Dana-Farber Cancer Institute, Boston, USA )

Selecting patients wisely for neoadjuvant therapy in HPB cancers

Dr Shailesh V. Shrikhande - Tata Memorial Hospital, Mumbai, India

Selecting patients wisely for neoadjuvant therapy in HPB cancers ( Dr Shailesh V. Shrikhande - Tata Memorial Hospital, Mumbai, India )

Assessment of suicide risk in cancer patients

Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India

Assessment of suicide risk in cancer patients ( Prof Sujit Sarkhel - SSKM Hospital, Kolkata, India )

Cancer journeys: Research from India

Ms. Soumita Ghose - Tata Medical Center, Kolkata

Cancer journeys: Research from India ( Ms. Soumita Ghose - Tata Medical Center, Kolkata )

Depression in cancer

Ms. Bidisha Samanta - Rocket Health, Kolkata, India

Depression in cancer ( Ms. Bidisha Samanta - Rocket Health, Kolkata, India )

Managing 'fear of recurrence' of cancer patients

Ms Bincy Mathew - Manipal Hospitals, Bangalore, India

Managing 'fear of recurrence' of cancer patients ( Ms Bincy Mathew - Manipal Hospitals, Bangalore, India )

Psychological issues in familial cancer

Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India

Psychological issues in familial cancer ( Dr Arnab Mukherjee - Tata Medical Center, Kolkata, India )

Pancreatic, hepatic and biliary malignancies

Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA

Pancreatic, hepatic and biliary malignancies ( Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA )

Administering systemic chemotherapy improves survival for patients with...

Dr Giacomo Bregni - Francis Crick Institute, London, England

Administering systemic chemotherapy improves survival for patients with resectable CRCLM ( Dr Giacomo Bregni - Francis Crick Institute, London, England )

More from ecancer